MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Post published:January 20, 2021 Post category:Press Release
Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference Post published:January 19, 2021 Post category:Press Release
Psyched Wellness Announces New OTCQB Ticker: PSYCF Post published:January 19, 2021 Post category:Press Release
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada Post published:January 19, 2021 Post category:Press Release
NeonMind Lists on the Frankfurt Stock Exchange Post published:January 19, 2021 Post category:Press Release
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development Post published:January 19, 2021 Post category:Press Release
Awakn Strengthens Scientific and Medical Leadership with Appointment of Chief Science Officer and Head of Ketamine Alcohol Use Disorder Practice Post published:January 19, 2021 Post category:Press Release
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders Post published:January 19, 2021 Post category:Press Release
Havn Life to Support Canadian Counterpart of Veterans’ Organization, Heroic Hearts Post published:January 18, 2021 Post category:Press Release
Lobe Sciences Announces Management Changes and New Director Post published:January 18, 2021 Post category:Press Release